|
Q4 2020
Filed on Feb 16, 2021
|
740
|
$108.07 - $143.15
$80K - $106K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
109
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
20,010
|
$16.87 - $22.93
$338K - $459K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
3,300
|
$28.42 - $38.35
$93.8K - $127K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
5,910
|
$17.19 - $21.91
$102K - $129K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
7,250
|
$26.19 - $32.84
$190K - $238K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
150
|
$66.66 - $111.74
$10K - $16.8K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
460
|
$39.5 - $42.13
$18.2K - $19.4K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
470
|
$24.37 - $43.1
$11.5K - $20.3K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,084
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
45,460
|
$9.35 - $13.17
$425K - $599K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
5,620
|
$11.38 - $15.51
$64K - $87.2K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
34,080
|
$5.89 - $10.47
$201K - $357K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
8,170
|
$50.39 - $63.72
$412K - $521K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
39,900
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
12,570
|
$18.62 - $24.56
$234K - $309K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
989
|
$18.64 - $20.53
$18.4K - $20.3K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,860
|
$14.8 - $20.37
$27.5K - $37.9K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
600
|
$18.83 - $25.79
$11.3K - $15.5K
|
|
Marinus Pharmaceuticals Inc
|
Q4 2020
Filed on Feb 16, 2021
|
699
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
17,580
|
$13.88 - $22.15
$244K - $389K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
200
|
$9.47 - $12.43
$1.89K - $2.49K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
2,180
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
4,675
|
$38.3 - $42.86
$179K - $200K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
19,470
|
$1.36 - $3.21
$26.5K - $62.5K
|
|
Kensington Cap Acquisition C
|
Q4 2020
Filed on Feb 16, 2021
|
521
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
250
|
$55.93 - $82.78
$14K - $20.7K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
3,190
|
$36.43 - $50.05
$116K - $160K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
9,180
|
$41.05 - $50.54
$377K - $464K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
10,880
|
$24.76 - $32.92
$269K - $358K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
412
|
$17.28 - $34.07
$7.12K - $14K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
1,270
|
$81.16 - $104.7
$103K - $133K
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
4,700
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
546
|
N/A
|
|
|
Q4 2020
Filed on Feb 16, 2021
|
300
|
$31.01 - $52.1
$9.3K - $15.6K
|
|
Allianzgi Dividend Int & Prm
|
Q4 2020
Filed on Feb 16, 2021
|
80
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
75
|
$0.92 - $2.4
$69 - $180
|
|
J P Morgan Exchange Traded F
|
Q3 2020
Filed on Nov 12, 2020
|
4,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
1,267
|
$27.04 - $62.21
$34.3K - $78.8K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
4,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
19
|
$251.37 - $310.2
$4.78K - $5.89K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
7,735
|
$8.2 - $12.07
$63.4K - $93.4K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
4,400
|
$4.11 - $6.45
$18.1K - $28.4K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
63
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
30
|
$28.28 - $53.6
$848 - $1.61K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
226
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
309
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
830
|
$15.11 - $27.58
$12.5K - $22.9K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
5
|
N/A
|
|